Acquired inhibitors in malignant and nonmalignant disease states
- 4 November 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (5) , S9-S13
- https://doi.org/10.1016/s0002-9343(91)80141-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIIIThrombosis Research, 1989
- Acquired factor VIII:C inhibitor (IgG) and positive direct Coombs' test (IgM) in a patient with lung carcinomaScandinavian Journal of Haematology, 1984
- Acquired inhibitor to human factor VIII associated with paraproteinaemia and subsequent development of chronic lymphatic leukaemia.BMJ, 1982
- A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIIIThrombosis and Haemostasis, 1981
- A Hemorrhagic Syndrome in Waldenström's Macroglobulinemia Secondary to Immunoadsorption of Factor VIIINew England Journal of Medicine, 1979
- Acquired factor VIII inhibitor in a patient with malignant lymphomaThe Lancet Healthy Longevity, 1974
- Two M Components (γGK and γML) in Different Cells of the Same PatientScandinavian Journal of Haematology, 1968
- Coagulation studies in different types of myeloma1Acta Medica Scandinavica, 1966
- A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin.Journal of Clinical Investigation, 1965
- Spontaneously occurring anticoagulant against antihemophilic globulin in a previously normal subjectThe American Journal of Medicine, 1963